home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Genetic News | search  
 

Regulating P53 Activity in Cancer Cells

 
  April, 9 2010 9:19
your information resource in human molecular genetics
 
     

The protein BRD7 activates p53 and could therefore suppress the development of cancerous tumours, reports a study online in Nature Cell Biology this week. The transcription factor p53 is a critically important tumour suppressor protein, as inactivation of the p53 pathway contributes to the development of cancer.

BRD7 expression is frequently lost in breast cancer, but it is currently not clear how BRD7 might inhibit tumour formation. Reuven Agami and colleagues show that BRD7 binds to and activates p53. BRD7 also regulates chromatin structure at p53-target genes, enabling more efficient transcription at these sites. As such, BRD7 loss permits oncogenic transformation of cultured human cells.

The researchers analyzed over two hundred human breast cancer samples and found that BRD7 expression was lost only in those tumours that contained functional p53. These findings suggest that selective BRD7 loss in human cancers provides an additional means of silencing the p53 pathway, and provide insight into how p53 transcriptional activity is regulated.

Author contact:

Reuven Agami (The Netherlands Cancer Institute, Amsterdam, Netherlands)
E-mail: r.agami@nki.nl

Abstract available online.

(C) Nature Cell Biology press release.


Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.